PMID- 11499870 OWN - NLM STAT- MEDLINE DCOM- 20020130 LR - 20131121 IS - 0884-0431 (Print) IS - 0884-0431 (Linking) VI - 16 IP - 8 DP - 2001 Aug TI - Characterization of tissue transglutaminase in human osteoblast-like cells. PG - 1477-85 AB - Tissue transglutaminase (tTG) is a calcium-dependent and guanosine 5'-triphosphate (GTP) binding enzyme, which catalyzes the post-translational modification of proteins by forming intermolecular epsilon(gamma-glutamyl)lysine cross-links. In this study, human osteoblasts (HOBs) isolated from femoral head trabecular bone and two osteosarcoma cell lines (HOS and MG-63) were studied for their expression and localization of tTG. Quantitative evaluation of transglutaminase (TG) activity determined using the [1,4 14C]-putrescine incorporation assay showed that the enzyme was active in all cell types. However, there was a significantly higher activity in the cell homogenates of MG-63 cells as compared with HOB and HOS cells (p < 0.001). There was no significant difference between the activity of the enzyme in HOB and HOS cells. All three cell types also have a small amount of active TG on their surface as determined by the incorporation of biotinylated cadaverine into fibronectin. Cell surface-related tTG was further shown by preincubation of cells with tTG antibody, which led to inhibition of cell attachment. Western blot analysis clearly indicated that the active TG was tTG and immunocytochemistry showed it be situated in the cytosol of the cells. In situ extracellular enzyme activity also was shown by the cell-mediated incorporation of fluorescein cadaverine into extracellular matrix (ECM) proteins. These results clearly showed that MG-63 cells have high extracellular activity, which colocalized with the ECM protein fibronectin and could be inhibited by the competitive primary amine substrate putrescine. The contribution of tTG to cell surface/matrix interactions and to the stabilization of the ECM of osteoblast cells therefore could by an important factor in the cascade of events leading to bone differentiation and mineralization. FAU - Heath, D J AU - Heath DJ AD - School of Biomedical Sciences, Queen's Medical Center, University of Nottingham, United Kingdom. FAU - Downes, S AU - Downes S FAU - Verderio, E AU - Verderio E FAU - Griffin, M AU - Griffin M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Bone Miner Res JT - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research JID - 8610640 RN - 0 (Fibronectins) RN - 0 (Fluoresceins) RN - EC 2.3.2.13 (Transglutaminases) RN - L90BEN6OLL (Cadaverine) SB - IM MH - Blotting, Western MH - Cadaverine/metabolism MH - Cell Adhesion/physiology MH - Cell Membrane/enzymology MH - Cells, Cultured MH - Extracellular Space/metabolism MH - Femur Head MH - Fibronectins/metabolism MH - Fluoresceins/metabolism MH - Humans MH - Osteoblasts/cytology/*enzymology MH - Osteosarcoma MH - Transglutaminases/*metabolism MH - Tumor Cells, Cultured EDAT- 2001/08/14 10:00 MHDA- 2002/01/31 10:01 CRDT- 2001/08/14 10:00 PHST- 2001/08/14 10:00 [pubmed] PHST- 2002/01/31 10:01 [medline] PHST- 2001/08/14 10:00 [entrez] AID - 10.1359/jbmr.2001.16.8.1477 [doi] PST - ppublish SO - J Bone Miner Res. 2001 Aug;16(8):1477-85. doi: 10.1359/jbmr.2001.16.8.1477.